Health-tech company Practo is shifting its growth strategy towards international markets, specifically the UAE and the US, after achieving its first full year of profitability in FY25 with an operating EBITDA of ₹15 crore. Despite a slight dip in revenue to ₹234 crore in FY25 from ₹242 crore in FY24, the company aims to revive topline growth through global expansion. Practo's core revenue streams include appointment booking, teleconsultations, and software solutions for healthcare providers.